{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:09Z","timestamp":1790629749368,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.046","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T12:18:47Z","timestamp":1466425127000},"page":"3979-3985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge"],"prefix":"10.1016","volume":"34","author":[{"given":"David C.","family":"Bulir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Kaushic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ashkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.046_b0005","unstructured":"Centers for Disease C, Prevention. CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morbidity and mortality weekly report, vol. 60; 2011. p. 370-3."},{"key":"10.1016\/j.vaccine.2016.06.046_b0010","unstructured":"WHO. Sexually transmitted infections (STIs); 2015."},{"key":"10.1016\/j.vaccine.2016.06.046_b0015","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMcp030542","article-title":"Clinical practice. Genital chlamydial infections","volume":"349","author":"Peipert","year":"2003","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2016.06.046_b0020","first-page":"471","article-title":"The immunology of the trachoma agent with a preliminary report on field trials on vaccine","volume":"2","author":"Bell","year":"1963","journal-title":"Investigative Ophthalmol."},{"key":"10.1016\/j.vaccine.2016.06.046_b0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1586\/erv.09.98","article-title":"Chlamydia vaccine candidates and tools for chlamydial antigen discovery","volume":"8","author":"Rockey","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.06.046_b0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0035","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1073\/pnas.1101756108","article-title":"Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines","volume":"108","author":"Finco","year":"2011","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"10.1016\/j.vaccine.2016.06.046_b0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.vaccine.2013.11.100","article-title":"Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model","volume":"32","author":"Olsen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0045","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0050","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/IAI.69.9.5908-5910.2001","article-title":"PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice","volume":"69","author":"Holder","year":"2001","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0055","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2009.11.076","article-title":"Amino acid residues 196\u2013225 of LcrV represent a plague protective epitope","volume":"28","author":"Quenee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0060","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.1302743","article-title":"Intradermal delivery of shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes","volume":"192","author":"Heine","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0070","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2009.02.095","article-title":"A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice","volume":"27","author":"Wang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0075","doi-asserted-by":"crossref","first-page":"e99315","DOI":"10.1371\/journal.pone.0099315","article-title":"Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infection","volume":"9","author":"Bulir","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.046_b0080","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.vaccine.2013.08.020","article-title":"Development status and future prospects for a vaccine against Chlamydia trachomatis infection","volume":"32","author":"Hafner","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0085","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/IAI.00859-13","article-title":"Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine","volume":"81","author":"Martinez-Becerra","year":"2013","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0090","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.vaccine.2013.04.045","article-title":"Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD","volume":"31","author":"Heine","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0095","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.vaccine.2013.04.012","article-title":"Parenteral immunization with IpaB\/IpaD protects mice against lethal pulmonary infection by Shigella","volume":"31","author":"Martinez-Becerra","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.046_b0100","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/IAI.00189-08","article-title":"Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1-Yersinia pestis","volume":"76","author":"Ivanov","year":"2008","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2009.11.001","article-title":"Type III secretion systems shape up as they ship out","volume":"13","author":"Marlovits","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CMR.00013-07","article-title":"Type III secretion systems and disease","volume":"20","author":"Coburn","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.06.046_b0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tim.2006.02.009","article-title":"Type III secretion: what\u2019s in a name?","volume":"14","author":"Desvaux","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0120","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/IAI.00159-11","article-title":"Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions","volume":"79","author":"Chellas-Gery","year":"2011","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2016.06.046_b0125","first-page":"5404","article-title":"Conserved type III secretion system exerts important roles in Chlamydia trachomatis","volume":"7","author":"Dai","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev immunol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.micpath.2008.01.005","article-title":"Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice","volume":"45","author":"Babiuk","year":"2008","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2016.06.046_b0140","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.166.5.3451","article-title":"Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract","volume":"166","author":"Gallichan","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12866-015-0498-1","article-title":"Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein","volume":"15","author":"Bulir","year":"2015","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/icb.2009.3","article-title":"Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice","volume":"87","author":"Carey","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2016.06.046_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.olq.0000148299.14513.11","article-title":"Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum","volume":"32","author":"Shah","year":"2005","journal-title":"Sex Transm Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T03:54:21Z","timestamp":1536638061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16304704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":31,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16304704"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}